New York State Teachers Retirement System Alnylam Pharmaceuticals, Inc. Transaction History

New York State Teachers Retirement System

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	SELL	$224.32 - $326.09 $333,563 - $484,895	-1,487 Reduced 88.62%	191 $62,000
Q1 2025 Apr 25, 2025	SELL	$233.07 - $290.7 $969,105 - $1.21 Million	-4,158 Reduced 71.25%	1,678 $453,000
Q4 2024 Jan 30, 2025	BUY	$232.27 - $300.43 $128,445 - $166,137	553 Added 10.47%	5,836 $1.37 Million
Q3 2024 Oct 25, 2024	BUY	$233.81 - $287.01 $1.24 Million - $1.52 Million	5,283 New	5,283 $1.45 Million

926

117M

1.25M

1.49M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $55.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of New York State Teachers Retirement System, based on Form 13F filings with the SEC.

Stay updated on New York State Teachers Retirement System with notifications on news.